SG Americas Securities LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 37.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 113,025 shares of the company’s stock after selling 66,713 shares during the quarter. SG Americas Securities LLC’s holdings in Colgate-Palmolive were worth $8,308,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently modified their holdings of CL. Parsec Financial Management Inc. boosted its position in Colgate-Palmolive by 0.5% during the second quarter. Parsec Financial Management Inc. now owns 30,081 shares of the company’s stock worth $2,156,000 after acquiring an additional 146 shares during the last quarter. Heritage Way Advisors LLC boosted its position in Colgate-Palmolive by 0.4% during the second quarter. Heritage Way Advisors LLC now owns 33,769 shares of the company’s stock worth $2,420,000 after acquiring an additional 146 shares during the last quarter. Bridger Capital Management LLC boosted its position in Colgate-Palmolive by 0.8% during the third quarter. Bridger Capital Management LLC now owns 18,265 shares of the company’s stock worth $1,243,000 after acquiring an additional 150 shares during the last quarter. Moloney Securities Asset Management LLC boosted its position in Colgate-Palmolive by 2.7% during the second quarter. Moloney Securities Asset Management LLC now owns 6,038 shares of the company’s stock worth $433,000 after acquiring an additional 157 shares during the last quarter. Finally, Cornerstone Advisors Inc. boosted its position in Colgate-Palmolive by 3.0% during the third quarter. Cornerstone Advisors Inc. now owns 5,399 shares of the company’s stock worth $397,000 after acquiring an additional 159 shares during the last quarter. Institutional investors own 76.09% of the company’s stock.
In other news, Chairman Ian M. Cook sold 17,750 shares of the firm’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $68.30, for a total value of $1,212,325.00. Following the transaction, the chairman now owns 995,075 shares of the company’s stock, valued at approximately $67,963,622.50. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Philip G. Shotts sold 8,919 shares of the firm’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $71.05, for a total transaction of $633,694.95. Following the completion of the transaction, the vice president now directly owns 50,399 shares in the company, valued at approximately $3,580,848.95. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 193,361 shares of company stock worth $13,722,098. 1.14% of the stock is currently owned by insiders.
NYSE:CL traded down $0.24 during trading hours on Friday, reaching $66.63. 3,082,162 shares of the company were exchanged, compared to its average volume of 3,535,509. The company has a debt-to-equity ratio of 43.94, a current ratio of 1.03 and a quick ratio of 0.25. The firm has a market cap of $57.34 billion, a price-to-earnings ratio of 22.43, a PEG ratio of 5.24 and a beta of 0.73. Colgate-Palmolive has a 52-week low of $57.51 and a 52-week high of $76.41. The stock has a 50 day simple moving average of $69.58 and a 200 day simple moving average of $71.58.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, November 1st. The company reported $0.71 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.70 by $0.01. The company had revenue of $3.93 billion for the quarter, compared to the consensus estimate of $3.95 billion. Colgate-Palmolive had a net margin of 15.04% and a return on equity of 6,492.71%. Colgate-Palmolive’s revenue was up 2.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.72 earnings per share. On average, analysts predict that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 23rd will be paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 2.58%. The ex-dividend date is Tuesday, October 22nd. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.
A number of analysts recently issued reports on the stock. Wells Fargo & Co raised their target price on shares of Colgate-Palmolive from $68.00 to $70.00 and gave the stock a “market perform” rating in a research report on Monday, July 29th. UBS Group decreased their target price on shares of Colgate-Palmolive from $82.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Citigroup raised their target price on shares of Colgate-Palmolive from $77.00 to $79.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 20th. Piper Jaffray Companies assumed coverage on shares of Colgate-Palmolive in a research report on Tuesday, August 13th. They set an “overweight” rating on the stock. Finally, Berenberg Bank assumed coverage on shares of Colgate-Palmolive in a research report on Wednesday, October 16th. They set a “sell” rating and a $58.00 target price on the stock. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $72.57.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Article: What does an outperform rating mean?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.